Karam Diaby, PhD, MSc, CRA
Karam Diaby currently serves as the Director, Health Economics and Value Evidence Partnership at Otsuka. Prior to joining Otsuka, Karam Diaby, CRA, MSc, Ph.D., was an Assistant Professor in the Department of Pharmaceutical Outcomes and Policy (POP) in the University of Florida (UF) College of Pharmacy. He also served as the Track Director for the […]
Gwen Darien
Gwen Darien is a longtime patient advocate who has played leadership roles in some of the country’s preeminent nonprofit organizations. As executive vice president for patient advocacy and engagement, Gwen leads programs that link PAF’s patient service programs to NPAF initiatives, with the goal of improving access to affordable, equitable quality health care. Called “a […]
Donna Cryer, JD
Donna R. Cryer, JD, is Founder and Chief Executive Officer of Global Liver Institute (GLI), the premier patient-driven liver health nonprofit operating with offices and partnerships across five continents. Moved by her own experience as a 28-year-old liver transplant recipient, Mrs. Cryer serves as a fierce advocate for the transformative potential of patient engagement in […]
Nakela Cook, MD, MPH
Nakela L. Cook is the Executive Director at the Patient-Centered Outcomes Research Institute (PCORI). She is a cardiologist and health services researcher with a distinguished career leading key scientific initiatives engaging patients, clinicians, and other healthcare stakeholders at some of the nation’s largest health research funders. Cook leads PCORI’s research, engagement, dissemination and implementation, and […]
Jennifer Bright, MPA
Jennifer Bright, Chief Engagement and Strategy Officer for the Center for Innovation & Value Research, brings over two decades of health care policy, issue management, patient advocacy, and executive leadership to the role. Bright is also founder and President of Momentum Health Strategies. She formerly served as executive director of the Society for Healthcare Epidemiology […]
Nicole Boschi, PhD
Nicole M. Boschi, PhD is the Director of Regulatory Affairs at the National Multiple Sclerosis Society. In this role, she works to build relationships with federal agencies to achieve a world free of MS. Dr. Boschi received her BS (cum laude) in Neuroscience from the University of Rochester and her MS and PhD in pharmacology […]
Greg Baker, RPh
As CEO, Greg Baker strategically develops EmsanaRx’s mission for drive better health, predictable costs and a partnership that puts employers in control. Greg has decades of experience in pharmacy as a pharmacist, businessman, and entrepreneur. He leads EmsanaRx in three core areas: 1. Cost Transparency, 2. Data Control and 3. Patient Health Improvement. He is […]
Jason Spangler, MD, MPH, FACPM
For nearly two decades, Dr. Spangler, Center for Innovation & Value Research Chief Executive Officer, has worked in the professional health policy and public health sector with pharmaceutical and non-profit organizations. Dr. Spangler joins the Center from his most recent role as Executive Medical Director and Director and Head of Global HTA Policy Strategy & […]
Ilisa Halpern Paul, MPP
Ilisa Halpern Paul is a senior policy advisor at Venable LLP in the firm’s Washington, DC office. Ilisa co-leads the firm’s Federal Health Policy team, drawing on more than 30 years of recorded success in helping established and start-up healthcare companies, health and hospital systems, provider associations, and nonprofit patient advocacy organizations advance their legislative, […]
Eberechukwu Onukwugha, MS, PhD
Eberechukwu Onukwugha, PhD is a Professor in the Department of Practice, Sciences, and Health Outcomes Research at the University of Maryland School of Pharmacy and is the Executive Director of Pharmaceutical Research Computing at the University of Maryland School of Pharmacy. She received a Bachelor of Arts in economics and French from the University at […]